Top Markets
Coin of the day
Hancock Jaffe Laboratories Hancock Jaffe Laboratories

Hancock Jaffe Laboratories

HJLI
Rank in Stocks #35033
Hancock Jaffe Laboratories, Inc. is a medical device company in its... Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.
Share Price
$10.38
Last synced: 2021-09-30
Market Cap
$4.55M
Change (1 day)
-1.98%
Change (1 year)
0.00%
Country
US
Trade Hancock Jaffe Laboratories (HJLI)

Category

Stock price history for Hancock Jaffe Laboratories (HJLI)
Highest end of day price: $9.10 on 2021-09-01

Lowest end of day price: $131.00 on 2018-05-01
Stock price history of Hancock Jaffe Laboratories from 2018 to 2026
Annual Stock Price Performance
Year Performance
2021 5.44%
2020 -25.89%
2019 -72.70%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US